Company Performance - MINISO Group Holding Limited Unsponsored ADR (MNSO) closed at $17.74, reflecting a -1.93% change from the previous day, underperforming the S&P 500's daily loss of 0.33% [1] - Over the past month, MNSO shares have decreased by 1.47%, while the Retail-Wholesale sector gained 0.67% and the S&P 500 increased by 4.07% [1] Upcoming Earnings - The upcoming earnings disclosure is highly anticipated, with a consensus estimate forecasting revenue of $672.03 million, representing a 21.03% growth compared to the same quarter last year [2] Annual Forecast - For the entire year, Zacks Consensus Estimates predict earnings of $1.12 per share and revenue of $2.9 billion, indicating changes of -2.61% for earnings and +22.75% for revenue compared to the previous year [3] Analyst Revisions - Recent revisions to analyst forecasts for MNSO are important as they reflect near-term business trends, with positive revisions indicating optimism about the business outlook [4] Zacks Rank - The Zacks Rank system currently rates MNSO as 5 (Strong Sell), with no changes in the consensus EPS estimate over the past month [6] Valuation Metrics - MNSO is trading at a Forward P/E ratio of 16.22, which is a discount compared to its industry's Forward P/E of 17.97 [7] - The company has a PEG ratio of 1.06, while the average PEG ratio for Retail - Apparel and Shoes stocks is 2.02, indicating a more favorable valuation relative to expected earnings growth [8] Industry Context - The Retail - Apparel and Shoes industry, part of the Retail-Wholesale sector, has a Zacks Industry Rank of 209, placing it in the bottom 16% of over 250 industries [8][9]

Company Performance - BRF's stock price decreased by 3.23% to $3.90, underperforming the S&P 500's daily loss of 0.33% [1] - Over the past month, BRF shares increased by 9.81%, outperforming the Consumer Staples sector's decline of 0.8% and the S&P 500's gain of 4.07% [1] Financial Projections - BRF is expected to report earnings of $0.11 per share, indicating no growth compared to the same quarter last year [2] - For the entire fiscal year, earnings are projected at $0.39 per share and revenue at $12.15 billion, reflecting increases of +8.33% and +11.05% respectively from the previous year [2] Analyst Sentiment - Recent revisions to analyst forecasts for BRF are important as they indicate changing near-term business trends and analysts' confidence in performance [3] Valuation Metrics - BRF has a Forward P/E ratio of 10.33, which is lower than the industry average of 16.17, suggesting it is trading at a discount [6] - The company has a PEG ratio of 0.25, significantly below the industry average PEG ratio of 1.63 [6] Industry Context - The Food - Miscellaneous industry, which includes BRF, has a Zacks Industry Rank of 185, placing it in the bottom 26% of over 250 industries [7] - Stronger industry groups, as indicated by the Zacks Industry Rank, tend to outperform weaker groups by a factor of 2 to 1 [7]

In the latest close session, Uber Technologies (UBER) was down 1.05% at $95.39. This change lagged the S&P 500's 0.33% loss on the day. At the same time, the Dow lost 0.63%, and the tech-heavy Nasdaq lost 0.22%. Shares of the ride-hailing company witnessed a gain of 12.59% over the previous month, beating the performance of the Computer and Technology sector with its gain of 5.24%, and the S&P 500's gain of 4.07%.Market participants will be closely following the financial results of Uber Technologies in its ...

Company Performance - Nu Holdings Ltd. ended the recent trading session at $12.83, showing a -1.53% change from the previous day's closing price, underperforming the S&P 500 which lost 0.33% [1] - The company's shares have increased by 8.58% over the last month, outperforming the Finance sector's gain of 3.2% and the S&P 500's gain of 4.07% [1] Upcoming Earnings - Nu Holdings Ltd. is set to disclose its earnings on August 14, 2025, with projected earnings of $0.12 per share, indicating no growth from the prior-year quarter [2] - The consensus estimate for revenue is $3.66 billion, reflecting a 28.32% increase compared to the year-ago quarter [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $0.54 per share and revenue at $14.9 billion, representing changes of +20% and +29.38% respectively from the prior year [3] - Recent changes to analyst estimates indicate optimism regarding the business and profitability [3] Valuation Metrics - Nu Holdings Ltd. has a Forward P/E ratio of 23.98, which is a premium compared to the industry average Forward P/E of 10.06 [6] - The company holds a PEG ratio of 0.74, while the average PEG ratio for the Banks - Foreign industry is 0.99 [6] Industry Context - The Banks - Foreign industry is part of the Finance sector and currently holds a Zacks Industry Rank of 26, placing it in the top 11% of over 250 industries [7] - The Zacks Industry Rank evaluates the strength of industry groups based on the average Zacks Rank of individual stocks, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [7]

Core Insights - The article compares two stocks in the Medical - Products sector: Smith & Nephew (SNN) and EssilorLuxottica Unsponsored ADR (ESLOY) to determine which is more attractive to value investors [1] Valuation Metrics - Smith & Nephew has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while EssilorLuxottica has a Zacks Rank of 3 (Hold) [3] - SNN has a forward P/E ratio of 15.83, significantly lower than ESLOY's forward P/E of 35.31, suggesting SNN may be undervalued [5] - The PEG ratio for SNN is 0.96, while ESLOY's PEG ratio is 4.52, indicating SNN's expected earnings growth is more favorable [5] - SNN's P/B ratio is 2.58 compared to ESLOY's P/B of 3.01, further supporting SNN's valuation attractiveness [6] - SNN has a Value grade of A, while ESLOY has a Value grade of D, highlighting SNN's superior valuation metrics [6]

Company Performance - BlackRock (BLK) closed at $1,104.05, marking a +1.41% move from the prior day, outperforming the S&P 500's daily gain of 0.28% [1] - The stock has risen by 9.61% in the past month, leading the Finance sector's gain of 2.79% and the S&P 500's gain of 4.37% [1] Earnings Estimates - BlackRock is set to release its earnings on July 15, 2025, with projected EPS of $10.77, indicating a 3.96% increase year-over-year [2] - Revenue is expected to be $5.38 billion, up 12.02% from the prior-year quarter [2] - For the full year, analysts expect earnings of $45.73 per share and revenue of $22.72 billion, reflecting changes of +4.86% and +11.33% respectively from last year [3] Analyst Sentiment - Recent modifications to analyst estimates for BlackRock indicate changing near-term business trends, with positive revisions reflecting analyst optimism [4] - The Zacks Rank system, which assesses these estimate changes, currently ranks BlackRock at 2 (Buy) [6] Valuation Metrics - BlackRock has a Forward P/E ratio of 23.81, compared to the industry average of 12.15, suggesting it is trading at a premium [7] - The company has a PEG ratio of 3.25, while the average PEG ratio for the Financial - Investment Management industry is 1.42 [8] Industry Context - The Financial - Investment Management industry is part of the Finance sector and holds a Zacks Industry Rank of 62, placing it in the top 26% of all industries [9]

Company Performance - Nutanix (NTNX) closed at $73.61, down 3.84% from the previous trading session, underperforming the S&P 500's gain of 0.28% [1] - Over the past month, Nutanix shares gained 3.35%, lagging behind the Computer and Technology sector's gain of 6.2% and the S&P 500's gain of 4.37% [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of $0.31, representing a 14.81% increase year-over-year [2] - Revenue is forecasted to be $642.3 million, indicating a 17.22% growth compared to the same quarter last year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $1.72 per share and revenue at $2.53 billion, reflecting increases of 31.3% and 17.58% respectively from the previous year [3] - Recent analyst estimate revisions are crucial as they indicate near-term business trends and reflect analyst optimism [3] Analyst Ratings and Valuation - The Zacks Rank system currently rates Nutanix at 3 (Hold), with a recent downward shift of 2.23% in the consensus EPS estimate [5] - Nutanix has a Forward P/E ratio of 44.41, significantly higher than the industry average of 20.02, indicating a premium valuation [6] - The PEG ratio for Nutanix stands at 2.19, compared to the industry average of 2.09 [6] Industry Context - The Computers - IT Services industry, part of the Computer and Technology sector, holds a Zacks Industry Rank of 87, placing it in the top 36% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - Target's stock closed at $104.74, reflecting a +2.26% change from the previous day's closing price, outperforming the S&P 500's daily gain of 0.28% [1] - The stock has increased by 4.4% over the past month, leading the Retail-Wholesale sector's gain of 0.87% and the S&P 500's gain of 4.37% [1] Earnings Forecast - Target is expected to report an EPS of $2.08, indicating a 19.07% decrease from the same quarter last year, with a projected quarterly revenue of $24.88 billion, down 2.26% year-over-year [2] - Full-year estimates predict earnings of $7.55 per share and revenue of $104.65 billion, representing year-over-year declines of -14.79% and -1.79%, respectively [3] Analyst Estimates and Rankings - Recent changes in analyst estimates are crucial for investors, as they reflect the evolving business landscape, with positive revisions indicating confidence in performance [3][4] - Target currently holds a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate having increased by 0.57% over the last 30 days [5] Valuation Metrics - Target's Forward P/E ratio stands at 13.57, which is a discount compared to the industry average of 20.89 [6] - The PEG ratio for Target is 2.93, compared to the Retail - Discount Stores industry's average PEG ratio of 2.76 [6] Industry Context - The Retail - Discount Stores industry is part of the Retail-Wholesale sector and has a Zacks Industry Rank of 90, placing it in the top 37% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - Intel's stock closed at $23.82, with a daily increase of +1.62%, outperforming the S&P 500's gain of 0.28% [1] - Over the past month, Intel's stock has risen by 13.35%, surpassing the Computer and Technology sector's gain of 6.2% and the S&P 500's gain of 4.37% [1] Upcoming Earnings - Intel's earnings report is expected on July 24, 2025, with a forecasted EPS of $0.01, reflecting a 50% decrease from the same quarter last year [2] - Revenue is projected to be $11.87 billion, indicating a 7.53% decline compared to the year-ago quarter [2] Full Year Projections - For the full year, earnings are estimated at $0.28 per share, representing a +315.38% change from the prior year, while revenue is projected at $50.8 billion, showing a -4.33% change [3] Analyst Estimates - Recent modifications to analyst estimates for Intel indicate near-term business trends, with upward revisions suggesting analysts' positivity towards the company's operations [4] - The Zacks Rank system, which reflects these estimate changes, currently rates Intel at 4 (Sell), with a recent downward shift of 3.8% in the EPS estimate [6] Valuation Metrics - Intel's Forward P/E ratio stands at 84.09, significantly higher than the industry average of 39 [7] - The company has a PEG ratio of 8.02, compared to the Semiconductor - General industry's average PEG ratio of 2.72 [7] Industry Context - The Semiconductor - General industry is part of the Computer and Technology sector, holding a Zacks Industry Rank of 62, placing it in the top 26% of over 250 industries [8]

Core Viewpoint - Investors in the Medical - Outpatient and Home Healthcare sector should consider Astrana Health, Inc. (ASTH) as a potentially better value option compared to Chemed (CHE) based on various financial metrics and rankings [1]. Group 1: Zacks Rank and Earnings Outlook - Astrana Health, Inc. has a Zacks Rank of 1 (Strong Buy), indicating a positive earnings estimate revision trend, while Chemed has a Zacks Rank of 4 (Sell) [3]. - The improving earnings outlook for ASTH suggests a favorable investment opportunity compared to CHE [7]. Group 2: Valuation Metrics - ASTH has a forward P/E ratio of 15.66, significantly lower than CHE's forward P/E of 20.47, indicating that ASTH may be undervalued [5]. - The PEG ratio for ASTH is 0.91, while CHE's PEG ratio is 2.09, further suggesting that ASTH offers better value considering expected earnings growth [5]. - ASTH's P/B ratio is 1.85 compared to CHE's P/B of 5.84, reinforcing the notion that ASTH is more attractively priced relative to its book value [6]. - Based on these metrics, ASTH has earned a Value grade of A, while CHE has a Value grade of C [6].